Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms
暂无分享,去创建一个
Alicia Fernandez-Fernandez | Romila Manchanda | Anthony J. McGoron | A. Fernandez-Fernandez | R. Manchanda | A. McGoron
[1] G. Storm,et al. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.
[2] Thommey P. Thomas,et al. Design and Function of a Dendrimer-Based Therapeutic Nanodevice Targeted to Tumor Cells Through the Folate Receptor , 2002, Pharmaceutical Research.
[3] Xiang Li,et al. Preparation of nanobubbles for ultrasound imaging and intracelluar drug delivery. , 2010, International journal of pharmaceutics.
[4] Y. S. Tarahovsky. “Smart” liposomal nanocontainers in biology and medicine , 2010, Biochemistry (Moscow).
[5] F. Dosio,et al. From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy , 2003, Tumori.
[6] H. Kantarjian,et al. Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] S. Basu,et al. Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation , 2010, International journal of nanomedicine.
[8] K. Leong,et al. Chitosan‐g‐PEG/DNA complexes deliver gene to the rat liver via intrabiliary and intraportal infusions , 2006, The journal of gene medicine.
[9] S. Sahoo,et al. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.
[10] A. Fernandez-Fernandez,et al. Simultaneous Delivery of Chemotherapeutic and Thermal-Optical Agents to Cancer Cells by a Polymeric (PLGA) Nanocarrier: An In Vitro Study , 2010, Pharmaceutical Research.
[11] T. Allen. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system , 1994 .
[12] Ick Chan Kwon,et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[13] Jennifer L West,et al. Nanoparticles for thermal cancer therapy. , 2009, Journal of biomechanical engineering.
[14] M. Paul,et al. 6-Mercaptopurine and Daunorubicin Double Drug Liposomes—Preparation, Drug-Drug Interaction and Characterization , 2005, Journal of liposome research.
[15] T. Takei,et al. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. , 1993, Journal of microencapsulation.
[16] A Paul Alivisatos,et al. Room-temperature single-nucleotide polymorphism and multiallele DNA detection using fluorescent nanocrystals and microarrays. , 2003, Analytical chemistry.
[17] R. Kanwar,et al. Foundation review : Antiangiogenic therapy using nanotechnological-based delivery system , 2011 .
[18] G. Gregoriadis,et al. Enzyme entrapment in liposomes , 1971, FEBS letters.
[19] L. Mayer,et al. Increased preclinical efficacy of irinotecan and floxuridine coencapsulated inside liposomes is associated with tumor delivery of synergistic drug ratios. , 2006, Oncology research.
[20] Sudesh Kumar Yadav,et al. Biodegradable polymeric nanoparticles based drug delivery systems. , 2010, Colloids and surfaces. B, Biointerfaces.
[21] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[22] Michael J Sailor,et al. Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery. , 2008, Angewandte Chemie.
[23] J. Irache,et al. Bioadhesive properties and biodistribution of cyclodextrin-poly(anhydride) nanoparticles. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[24] John M. Walker,et al. Molecular Biology and Biotechnology , 1988 .
[25] Katayoun Derakhshandeh,et al. Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients , 2010, International journal of nanomedicine.
[26] V. Torchilin,et al. Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo , 1991, FEBS letters.
[27] Qiang Zhang,et al. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[28] M. Porter,et al. Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels. , 2003, Analytical chemistry.
[29] Aibing Yu,et al. Inorganic nanoparticles as carriers for efficient cellular delivery , 2006 .
[30] G. Birrenbach,et al. Polymerized micelles and their use as adjuvants in immunology. , 1976, Journal of pharmaceutical sciences.
[31] A. Giatromanolaki,et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Janko Kos,et al. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[33] I. Bakker-Woudenberg,et al. Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[34] Zheng-Rong Lu,et al. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier. , 2009, Biomaterials.
[35] Michael J Sailor,et al. SERS‐Coded Gold Nanorods as a Multifunctional Platform for Densely Multiplexed Near‐Infrared Imaging and Photothermal Heating , 2009, Advanced materials.
[36] Zhuang Liu,et al. Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.
[37] K. Parang,et al. Development of cytarabine prodrugs and delivery systems for leukemia treatment , 2010, Expert opinion on drug delivery.
[38] R. Kannan,et al. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. , 2010, Drug discovery today.
[39] Qian Yang,et al. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. , 2010, Biomaterials.
[40] C. Yeh,et al. Multifunctional polymeric nanoparticles for combined chemotherapeutic and near-infrared photothermal cancer therapy in vitro and in vivo. , 2010, Chemical communications.
[41] D. P. O'Neal,et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.
[42] Jiwei Huang,et al. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging. , 2010, Biomaterials.
[43] I. Kwon,et al. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol-chitosan nanoaggregates by EPR effect. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[44] Xiaohua Huang,et al. Peptide-conjugated gold nanorods for nuclear targeting. , 2007, Bioconjugate chemistry.
[45] V. Castranova,et al. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? , 2009, Pharmacology & therapeutics.
[46] R. Sinclair,et al. Multiplex detection of protease activity with quantum dot nanosensors prepared by intein-mediated specific bioconjugation. , 2008, Analytical Chemistry.
[47] A. Maitra,et al. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[48] Martin W. Brechbiel,et al. Dendrimer-based macromolecular MRI contrast agents: characteristics and application. , 2003 .
[49] A. Fernandez-Fernandez,et al. Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms. , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[50] F. Caponigro,et al. Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[51] A. Spira,et al. Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Bevacizumab in First-line Patients with Advanced Nonsquamous Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[52] F. Mollinedo,et al. Lipid nanomedicines for anticancer drug therapy. , 2009, Journal of biomedical nanotechnology.
[53] Sheela M. Waugh,et al. 2′-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165) , 1998, The Journal of Biological Chemistry.
[54] J. Kreuter. Nanoparticles and microparticles for drug and vaccine delivery. , 1996, Journal of anatomy.
[55] M. Ziepert,et al. High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[56] D. Senger,et al. Matrix‐specific activation of Src and Rho initiates capillary morphogenesis of endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] H. Kourlas,et al. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. , 2006, Clinical therapeutics.
[58] G Toffoli,et al. Overexpression of folate binding protein in ovarian cancers , 1997, International journal of cancer.
[59] A. Anagnostopoulos,et al. The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia , 2005, Leukemia & lymphoma.
[60] Ho Sup Yoon,et al. Co-delivery of drugs and DNA from cationic core–shell nanoparticles self-assembled from a biodegradable copolymer , 2006, Nature materials.
[61] Jens Ricke,et al. Magnetic nanoparticles for interstitial thermotherapy – feasibility, tolerance and achieved temperatures , 2006, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[62] S. Bhatia,et al. Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.
[63] Ulrik B Nielsen,et al. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[64] J. Richie,et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. Han,et al. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. , 2010, Bioconjugate chemistry.
[66] G. Gregoriadis,et al. Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. , 1972, European journal of biochemistry.
[67] Craig A. Poland,et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.
[68] W. Mark Saltzman,et al. Targeted for drug delivery , 2005 .
[69] Leaf Huang,et al. Nanoparticles targeted with NGR motif deliver c-myc siRNA and doxorubicin for anticancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[70] P. Opolon,et al. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. , 2006, Human gene therapy.
[71] S. Chae,et al. Conjugated chitosan as a novel platform for oral delivery of paclitaxel. , 2008, Journal of medicinal chemistry.
[72] Murali M. Yallapu,et al. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. , 2010, Journal of colloid and interface science.
[73] David J. Waxman,et al. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment , 2008, Molecular Cancer Therapeutics.
[74] A. Fernandez-Fernandez,et al. Comparative Study of the Optical and Heat Generation Properties of IR820 and Indocyanine Green , 2012, Molecular imaging.
[75] P. Baldrick. The safety of chitosan as a pharmaceutical excipient. , 2010, Regulatory toxicology and pharmacology : RTP.
[76] Zhuang Liu,et al. Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.
[77] F. Szoka,et al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas , 2006, Proceedings of the National Academy of Sciences.
[78] K. Ulbrich,et al. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. , 1995, European journal of cancer.
[79] J. Hong,et al. A single intratracheal instillation of single-walled carbon nanotubes induced early lung fibrosis and subchronic tissue damage in mice , 2011, Archives of Toxicology.
[80] E. Wickstrom,et al. Single-wall carbon nanotubes with adsorbed antibodies detect live breast cancer cells , 2005 .
[81] L'Hocine Yahia,et al. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. , 2003, Biomaterials.
[82] T. Minko,et al. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. , 2008, Nanomedicine.
[83] Hong Xu,et al. Fluorescent, superparamagnetic nanospheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment. , 2010, ACS nano.
[84] V. Torchilin,et al. Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody , 2009, Clinical Cancer Research.
[85] Ick Chan Kwon,et al. New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy , 2009 .
[86] G. Devi,et al. siRNA-based approaches in cancer therapy , 2006, Cancer Gene Therapy.
[87] M. Stevens,et al. Engineering nanocomposite materials for cancer therapy. , 2010, Small.
[88] J. B. Hall,et al. Characterization of nanoparticles for therapeutics. , 2007, Nanomedicine.
[89] G. Liu,et al. Preparation of Fe3O4–chitosan nanoparticles used for hyperthermia , 2010 .
[90] C. Lehr,et al. PLGA Nanoparticles Stabilized with Cationic Surfactant: Safety Studies and Application in Oral Delivery of Paclitaxel to Treat Chemical-Induced Breast Cancer in Rat , 2009, Pharmaceutical Research.
[91] M. Torbenson,et al. Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery , 2006, International journal of nanomedicine.
[92] Li Yang,et al. Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma. , 2010, Journal of pharmaceutical sciences.
[93] S. Remick,et al. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[94] Chenjie Xu,et al. PET/MRI Dual-Modality Tumor Imaging Using Arginine-Glycine-Aspartic (RGD)–Conjugated Radiolabeled Iron Oxide Nanoparticles , 2008, Journal of Nuclear Medicine.
[95] D. Mishra,et al. Chitosan nanoparticles: a promising system in novel drug delivery. , 2010, Chemical & pharmaceutical bulletin.
[96] P Couvreur,et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. , 2000, Biomaterials.
[97] Bin Liu,et al. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. , 2010, Biomaterials.
[98] Neil Desai,et al. Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[99] Eun-Mi Kim,et al. Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. , 2009, International journal of pharmaceutics.
[100] Breimer. Future challenges for drug delivery research. , 1998, Advanced drug delivery reviews.
[101] L. Stanberry,et al. VivaGel™ (SPL7013 Gel): A candidate dendrimer – microbicide for the prevention of HIV and HSV infection , 2007, International journal of nanomedicine.
[102] Hedi Mattoussi,et al. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.
[103] Chen-Zhong Li,et al. Whole cell based electrical impedance sensing approach for a rapid nanotoxicity assay , 2010, Nanotechnology.
[104] T. Park,et al. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[105] Christine Robinson,et al. Preclinical safety testing of biotechnology-derived pharmaceuticals , 2004, Molecular biotechnology.
[106] Omid C Farokhzad,et al. Co‐Delivery of Hydrophobic and Hydrophilic Drugs from Nanoparticle–Aptamer Bioconjugates , 2007, ChemMedChem.
[107] Xiaogang Peng,et al. Luminescent CdSe/CdS core/shell nanocrystals in dendron boxes: superior chemical, photochemical and thermal stability. , 2003, Journal of the American Chemical Society.
[108] Kyung-Hwa Yoo,et al. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. , 2009, ACS nano.
[109] Jun Li,et al. Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer* , 2010, The Journal of Biological Chemistry.
[110] M. Brandl. Liposomes as drug carriers: a technological approach. , 2001, Biotechnology annual review.
[111] Jin Chang,et al. PLGA/polymeric liposome for targeted drug and gene co-delivery. , 2010, Biomaterials.
[112] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[113] N. K. Jain,et al. Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics , 2009, Journal of microencapsulation.
[114] Christine Jérôme,et al. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[115] K. Janes,et al. Chitosan nanoparticles as delivery systems for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[116] K. Avgoustakis,et al. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. , 2004, Current drug delivery.
[117] T. Leiner,et al. Cardiac cine MRI: comparison of 1.5 T, non-enhanced 3.0 T and blood pool enhanced 3.0 T imaging. , 2008, European journal of radiology.
[118] T. Park,et al. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. , 2010, Biomaterials.
[119] P. Couvreur,et al. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[120] Shiladitya Sengupta,et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.
[121] Lawrence Mayer,et al. In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. , 2009, Leukemia research.
[122] S. Sahoo,et al. Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[123] M. Salzberg,et al. Current Concepts of Treatment Strategies in Advanced or Recurrent Ovarian Cancer , 2005, Oncology.
[124] Thommey P. Thomas,et al. Dendrimer-based tumor cell targeting of fibroblast growth factor-1. , 2010, Bioorganic & medicinal chemistry letters.
[125] Philip E. Bourne,et al. CE-MC: a multiple protein structure alignment server , 2004, Nucleic Acids Res..
[126] H. von Briesen,et al. Preparation and characterisation of antibody modified gelatin nanoparticles as drug carrier system for uptake in lymphocytes. , 2005, Biomaterials.
[127] Amit Jain,et al. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. , 2011, Biomaterials.
[128] Yan Zhang,et al. Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[129] Patrick Couvreur,et al. A Nanomedicine Transports a Peptide Caspase-3 Inhibitor across the Blood–Brain Barrier and Provides Neuroprotection , 2009, The Journal of Neuroscience.
[130] H. Ueno,et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin , 2004, British Journal of Cancer.
[131] M. Shive,et al. Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[132] Douglas A Christensen,et al. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. , 2008, Ultrasonics.
[133] Xiu-fen Lei,et al. Measurement of DNA mismatch repair activity in live cells. , 2004, Nucleic acids research.
[134] H. Maeda,et al. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[135] Prashant K. Jain,et al. Plasmonic photothermal therapy (PPTT) using gold nanoparticles , 2008, Lasers in Medical Science.
[136] J. Shea,et al. Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging. , 2010, Molecular pharmaceutics.
[137] S. Haam,et al. Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. , 2007, Angewandte Chemie.
[138] Federica Chiellini,et al. Chitosan—A versatile semi-synthetic polymer in biomedical applications , 2011 .
[139] Changren Zhou,et al. Polysaccharides-based nanoparticles as drug delivery systems. , 2008, Advanced drug delivery reviews.
[140] Michael B. Hall,et al. Dendritic macromolecules: synthesis of starburst dendrimers , 1986 .
[141] Kwangmeyung Kim,et al. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[142] Pai-Chi Li,et al. HER-2 Antibody Conjugated Gold Nano Rod for in Vivo Photothermal Therapy , 2008, 2008 8th IEEE Conference on Nanotechnology.
[143] Zhuo Georgia Chen,et al. Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.
[144] E. Wickstrom,et al. Single-wall carbon nanotube nanobomb agents for killing breast cancer cells , 2005 .
[145] Shimon Weiss,et al. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides. , 2004, Journal of the American Chemical Society.
[146] H. Maeda,et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[147] Y. Jeong,et al. Polymeric nanoparticle composed of fatty acids and poly(ethylene glycol) as a drug carrier. , 2003, International journal of pharmaceutics.
[148] Ick Chan Kwon,et al. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring. , 2010, Journal of Controlled Release.
[149] Helena R. Chang,et al. Trastuzumab‐based neoadjuvant therapy in patients with HER2‐positive breast cancer , 2010, Cancer.
[150] Chad A Mirkin,et al. Multiplexed detection of protein cancer markers with biobarcoded nanoparticle probes. , 2006, Journal of the American Chemical Society.
[151] Feng Liu,et al. Non‐immunostimulatory nonviral vectors , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[152] Xiangrong Song,et al. Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[153] J. Mcvie,et al. Albumin microspheres for intra-arterial tumour targeting. I: Pharmaceutical aspects , 1985 .
[154] P. Low,et al. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. , 2005, Analytical biochemistry.
[155] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[156] Kemin Wang,et al. A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. , 2009, Journal of biomedical nanotechnology.
[157] Sun‐mi Lee,et al. Synergistic Cancer Therapeutic Effects of Locally Delivered Drug and Heat Using Multifunctional Nanoparticles , 2010, Advanced materials.
[158] S. Dakhil,et al. Improved regional selectivity of hepatic arterial bcnu with degradable microspheres , 1982, Cancer.
[159] S. Nair,et al. Novel chitin and chitosan nanofibers in biomedical applications. , 2010, Biotechnology advances.
[160] Forrest M Kievit,et al. PEI–PEG–Chitosan‐Copolymer‐Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection , 2009, Advanced functional materials.
[161] B. Axelsson. Liposomes as carriers for anti-inflammatory agents , 1989 .
[162] Keon Wook Kang. Preliminary Pre-Clinical Results and Overview on PET/MRI/Fluorescent Molecular Imaging , 2010 .
[163] D. Wei,et al. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles. , 2010, Biomaterials.
[164] J. Soria,et al. Use of angiogenesis inhibitors in tumour treatment. , 2005, European journal of cancer.
[165] T. Allen,et al. Ligand-targeted liposomes for cancer treatment. , 2005, Current drug delivery.
[166] Kam W Leong,et al. Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. , 2011, ACS nano.
[167] Ji-Xin Cheng,et al. Controlling the cellular uptake of gold nanorods. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[168] K. Gupta,et al. Linear polyethylenimine-graft-chitosan copolymers as efficient DNA/siRNA delivery vectors in vitro and in vivo. , 2012, Nanomedicine : nanotechnology, biology, and medicine.
[169] L. Curiel,et al. Synergistic inhibitory effect of high‐intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma , 2005, BJU international.
[170] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[171] Xin Liu,et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[172] R. Banerjee,et al. Liposomes: Applications in Medicine , 2001, Journal of biomaterials applications.
[173] Howard,et al. Collected studies on immunity , 2009 .
[174] Chad A Mirkin,et al. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange , 2006, Nature Protocols.
[175] T. Niidome,et al. A simple set-and-mix assay for screening of protein kinase inhibitors in cell lysates. , 2011, Analytical biochemistry.
[176] K. Ishii,et al. Delivery of Na/I Symporter Gene into Skeletal Muscle Using Nanobubbles and Ultrasound: Visualization of Gene Expression by PET , 2010, Journal of Nuclear Medicine.
[177] G. Keating,et al. Bevacizumab: in first-line treatment of advanced and/or metastatic renal cell carcinoma. , 2008, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.
[178] K. Gelmon,et al. Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[179] Jian Zhang,et al. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection. , 2002, Human gene therapy.
[180] J. Couzin. Nanoparticles Cut Tumors' Supply Lines , 2002, Science.
[181] M. Kohl,et al. Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique. , 1998, Physics in medicine and biology.
[182] R. Weissleder,et al. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.
[183] T. Ponchon,et al. In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in the rat. , 1974, British Journal of Cancer.
[184] J. Dijkstra,et al. The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenously injected liposomes. Effects of lanthanum and gadolinium salts. , 1981, Biochimica et biophysica acta.
[185] Vishal Saxena,et al. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. , 2006, International journal of pharmaceutics.
[186] I. Kwon,et al. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[187] P. Lund-johansen,et al. The dye dilution method for measurement of cardiac output. , 1990, European heart journal.
[188] T. Bettinger,et al. Chitosan-Based Vector/DNA Complexes for Gene Delivery: Biophysical Characteristics and Transfection Ability , 1998, Pharmaceutical Research.
[189] Y. Pei,et al. Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. , 2010, Biomaterials.
[190] P. Fong,et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[191] M. Shive,et al. Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .
[192] P. Couvreur,et al. Preparation and in vitro evaluation of chitosan nanoparticles containing a caspase inhibitor. , 2005, International journal of pharmaceutics.
[193] N. Nelken,et al. Advances in stent technology and drug-eluting stents. , 2004, The Surgical clinics of North America.
[194] Ick Chan Kwon,et al. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[195] Sang‐wook Lee,et al. Ki‐67 expression as a prognostic factor in diffuse large B‐cell lymphoma patients treated with rituximab plus CHOP , 2010, European journal of haematology.
[196] J. Luong,et al. Fluorescence properties of gold nanorods and their application for DNA biosensing. , 2005, Chemical communications.
[197] J. Duncan,et al. Noninvasive fluorescence detection of hepatic and renal function. , 1998, Journal of biomedical optics.
[198] Alicia Fernandez-Fernandez,et al. Preparation and characterization of a polymeric (PLGA) nanoparticulate drug delivery system with simultaneous incorporation of chemotherapeutic and thermo-optical agents. , 2010, Colloids and surfaces. B, Biointerfaces.
[199] B Ruozi,et al. PLA/PLGA nanoparticles for sustained release of docetaxel. , 2006, International journal of pharmaceutics.
[200] S. Nie,et al. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.